Managing patients with antipsychotic drug-induced hyperprolactinaemia
Intended for healthcare professionals
CPD Previous     Next

Managing patients with antipsychotic drug-induced hyperprolactinaemia

Adrian Jones Nurse consultant, Adult Mental Health, Wrexham Maelor Hospital, North East Wales NHS Trust. Wrexham
Martin Jones Associate director of nursing, Surrey and Borders Partnership NHS Foundation Trust, Frimley, Surrey, Surrey University, Guildford

This article outlines a range of interventions that mental health nurses can use in the management of patients with hyperprolactinaemia induced by antipsychotic medication. The article is aimed primarily at mental health nurse prescribers, but is relevant to all mental health nurses to inform their care of people at risk of developing an elevated prolactin level.

Nursing Standard. 23, 6, 48-55. doi: 10.7748/ns2008.10.23.6.48.c6709

Correspondence

adrian.jones@new-tr.wales.nhs.uk

Peer review

This article has been subject to double blind peer review

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more